N HEJ is a complex multicomponent process, which is conceptually divided into three steps: DNA end synapsis, processing, and ligation. The Ku70-Ku80 heterodimer (Ku) recognizes DNA ends 1 and recruits DNA-PKcs to form the DNA-PK holoenzyme, which interacts with another equivalent holoenzyme to form a synaptic complex 2 . Through autophosphorylation, the holoenzyme then provides a platform for assembly and regulation of downstream components 3-8 . For instance, DNA-PKcs recruits Artemis to open the DNA hairpin structure during V(D)J recombination 9,10 . Although PAXX has recently been identified as important for NHEJ, its role remains unclear [11][12][13] [14] . XRCC4 and XLF interact with each other and form filament structures [15] [16] [17] [18] [19] . The XLF-XRCC4 complexes interact with DNA-PK assembled at DNA ends and are believed to spatially bridge two DNA ends to facilitate ligation of the break by ligase IV (refs 20,21 ). Although the overall process is understood, with the key components identified and characterized through various approaches, critical information concerning the forces that hold DNA ends together, the kinetics of assembly and disassembly of NHEJ complexes, and the robustness of the repair pathway to fluctuations in complex composition remain unknown 22,23 . Here, we used single-molecule experimentation in conjunction with a novel DNA substrate to enable mechanical and energetic analysis of molecular interactions across a DNA break and address these questions.
Results
DNA molecular forceps sustain a functional NHEJ reaction. To objectively and quantitatively measure the properties of complex molecular synapsis and interactions, we developed a DNA-scaffoldbased single-molecule assay that permits the observation of repeated cycles of synapsis and rupture. Microscopic properties such as the kinetics of formation and lifetime of synapsis can be derived from such assays ( Fig. 1a) . Briefly, the DNA system consists of two linear double-strand DNA (dsDNA) segments ~1,510 bp in length that are connected to each other by a third double-strand DNA segment, termed a 'bridge' , of ~690 bp (Methods and Supplementary Fig. 1 ). The bridge is anchored 58 bp away from the ends of each DNA segment it tethers, allowing the ends to fluctuate freely as they face each other and providing ample space for loading of NHEJ components 6, 24, 25 . We attached one end of this construct to a digoxigeninmodified glass surface and the other end to a streptavidin-coated magnetic bead via 1-kb digoxigenin-or biotin-labeled DNA fragments attached to either end of the ~3.6-kbp construct. With a magnetic trap and computer-aided video microscopy, we applied a vertical extending force, F, to the bead and, thus, to the construct, while imaging the position of the magnetic bead above the surface 26 . This system allows real-time monitoring of DNA end synapsis by measuring the molecule's overall extension, l. If there is no synapsis between the DNA ends, then the extension of the ~3.6-kbp construct under a 1.4 picoNewton (pN) force (1 pN = 1 × 10 −12 N) is predicted to be 1,085 nm, on the basis of the worm-like chain (WLC) model that describes the mechanical properties of DNA 27 . If there is synapsis between the DNA ends, then the bridge no longer contributes to extension of the system, which is predicted to be only 913 nm, or 172 nm shorter than in the absence of synapsis.
We first show that this system can faithfully recapitulate complete NHEJ of blunt-end DSBs (Fig. 1b) . We subjected the DNA to digestion with the SmaI restriction enzyme, assembled constructs in the magnetic trap (~25-50 constructs per field of view), and introduced the full complement of human NHEJ components into the reaction chamber: 10 nM Ku, 100 pM DNA-PKcs, 20 nM PAXX, 20 nM XLF, and 20 nM XRCC4-ligase IV ( Supplementary Fig. 1c,d) . We repeatedly cycled the force applied to the DNA between a low and high value with a 450-s period (F low = 0.04 pN for ~225 s, F high = 1.4 pN for ~225 s); in the low-force state, the DNA ends are free to encounter each other, whereas in the high-force state, we can reliably interrogate the status of the DNA ends. After one or two traction cycles, we frequently observed a DNA state with reduced extension (Fig. 1b ) that never recovered its initial extension length, indicative of successful DNA ligation. Successful ligation of the blunt DNA ends of the construct generates a SmaI site. Thus, after disrupting residual NHEJ components with 0.2% SDS and then washing out the detergent (Methods), we added SmaI into the reaction, and the initial DNA state was restored via an abrupt increase in DNA extension, Δ l = 161 ± 2 nm (s.e.m., n = 28 cleavage events; Fig. 1c ). This repairspecific cleavage reaction provides a length-change calibration that we can then use as a signature of bona fide, specific interactions between the ends of the DNA construct. Most DNA molecules (36 out of 50, or 72%) were repaired within the first few traction cycles ( Fig. 1d ), underscoring the robust nature of DSB repair in this system when all components are present. Ligation was still observed, albeit at lower efficiency, when PAXX, XLF, or the XRCC4 N-and C-terminal domains were individually omitted from the reaction ( Table 1) . No ligation was observed when DNA-PKcs or ligase IV was omitted from the assay (Table 1) or if the DNA ends were dephosphorylated (discussed below).
The ligated DNA's ability to supercoil demonstrated that a double ligation event occurred, in which both strands of the DNA ligated to their counterparts at the other DNA end ( Supplementary  Fig. 2a ). We also show ( Supplementary Fig. 2b-d ) that T4 DNA ligase, although capable of efficiently ligating the construct prepared with overhanging ends (via XmaI digestion), was unable to efficiently ligate the construct with blunt ends, underscoring the requirement in vivo for robust molecular pathways to repair noncomplementary DSBs. We conclude that this DNA system functionally recapitulates human NHEJ at single-molecule resolution and thus provides a means to evaluate the contribution of each reaction component to synaptic stability.
Stepwise assembly of the human NHEJ machinery. We progressively assembled the NHEJ machinery and assayed for DNA end synapsis using the force-modulation method described above. We found that the minimal combination of DNA-PK holoenzyme (DNA-PKcs + Ku) and PAXX is necessary to observe frequent, second-scale interactions between the two DNA ends ( Fig. 2a,b and Supplementary Table 1 ). In this assay, an interaction was detected as a transient plateau in the DNA extension signal obtained upon increasing the force from F low to F high , where the duration of the plateau reflects the lifetime of the end interaction. The histogram depicting the distribution of observed Δ l values ( Fig. 2c ) displays a Gaussian peak located close to the expected amplitude (166 ± 1 nm s.e.m., n = 129 events). Comparing the change in DNA extension at the end of the plateau to our calibrated length-change standard obtained by specific recleavage of the repaired DNA ends confirmed that we are detecting bona fide interactions between the ends of the DNA construct. We designated those interaction events within three s.d. of the likeliest value as 'synaptic' . The lifetime distribution for synaptic events follows single-exponential behavior with an average, t synapsis , of 2.2 ± 0.3 s (s.e.m., n = 98 events) ( Fig. 2d ). Synapsis frequency, defined as the fraction of force-modulation cycles in which we observed a synaptic event, is ~6% (102 synaptic events out of 1,611 force-modulation cycles collected on ~90 DNA substrates; Supplementary Table 1 ).
These synaptic events did not substantially depend on the phosphorylation state of the DNA ends ( Fig. 3a) . Notably, synaptic events were abolished when we replaced wild-type PAXX with a mutant (V199A and F201A) incapable of interacting with the Ku subunit of the DNA-PK holoenzyme ( Fig. 3b ). XLF was unable to substitute for PAXX ( Fig. 3c ) despite its ability to interact with Ku 28, 29 . Neither DNA-PK holoenzyme nor PAXX on their own generated synapsis on the 2-s scale ( Fig. 3d,e ). We conclude that the 'upstream' components Ku, DNA-PKcs and PAXX sustain formation of DNA end synapsis that can resist up to ~1 pN traction forces (0.15 kCal/ mol × nm) for second time scales and that PAXX plays a central role in stable bridging of the gap between the two DNA ends.
To assess the role of the 'downstream' NHEJ components XRCC4, XLF and ligase IV, we added them in combination with the previously examined 'upstream' components to generate a 'complete' reaction ( Fig. 4 ). However, in contrast to the prior assays containing all components, in this case, we dephosphorylated the DNA ends to prevent ligation and to enable us to repeatedly interrogate the construct. We observed long-lived synaptic interactions: Supplementary Fig. 3a -c) resulted in a short synaptic lifetime similar to that observed in the presence of Ku, DNA-PKcs and PAXX with dephosphorylated DNA substrate ( Fig. 3a ), i.e., on the order of 2-3 s. This finding supports and extends observations that XRCC4, XLF and ligase IV are involved in a series of joint interactions and may act as a modular, functional unit of NHEJ, in which ligase IV interacts with the coiled-coil (cc) region of XRCC4 (ccXRCC4, corresponding to residues 138-213), whose N-terminal domain in turn associates with XLF 21, 30 . Removing any one of these three components would thus abolish the stabilizing effect of this functional unit. The same results were obtained when these assays were repeated using a phosphorylated DNA substrate (compare Fig. 2 and Supplementary Fig. 3d -f).
Replacing ligase IV with a catalytically inactive mutant (K273A; Supplementary Figs . 1d and 3g) resulted in a synaptic lifetime of 34.5 ± 6.9 s (s.e.m., n = 82 events). The modest impact on synapsis lifetime indicates that this component could still sustain the web of interactions necessary for downstream components to stabilize synapsis by DNA-PK and PAXX. Surprisingly, stable interactions were observed when wild-type XLF was replaced by a XLF 1-233 mutant deficient for interaction with Ku (44 ± 12.6 s, s.e.m., n = 84 events; Supplementary Fig. 3h ). In contrast, removing DNA-PKcs from the complete reaction essentially abolished synapsis ( Supplementary  Fig. 3i ). Synapsis was also abolished when both XLF and PAXX were omitted from the complete reaction ( Supplementary Fig. 3j ), thus supporting and extending a recently described overlapping function between XLF and PAXX and the resulting synthetic embryonic lethality observed in double-knockout mouse models 31, 32 . We note that the combination of XLF, XRCC4, and ligase IV does not support synapsis formation under the physiological salt conditions employed in this study ( Supplementary Fig. 4 ).
To further investigate the role of PAXX, we removed it from the complete reaction and observed a seven-fold reduction in synaptic lifetime compared to when PAXX was present (9 ± 1.8 s, s.e.m., n = 77 events; Supplementary Fig. 5a -c). We used these conditions to probe the effect of the traction force on synaptic lifetime. We observed that varying F high from 0.1 pN to 4.7 pN had no substantial effect on the lifetime of synapsis ( Supplementary Fig. 5d ). This finding indicates that the second-to-minute lifetimes we measured are relevant to the kinetics of NHEJ in vivo, where the forces acting on broken DNA ends are essentially diffusive. We also note that substituting the PAXX mutant for wild-type PAXX produced roughly the same reduction in synaptic lifetime as that of removing PAXX entirely from the reaction (in this case to 5.4 ± 1.3 s; Supplementary Fig. 5e -g).
Discussion
We report that synaptic junctions of varied composition can resist picoNewton-scale forces for times ranging from seconds to minutes. Presumably, this is a reflection of actual commitment to repair. On the basis of these observations, we propose a simple model for NHEJ synapsis (Fig. 5 ). Taking the 66-s lifetime of the complete synaptic junction as a baseline, we find that removing PAXX is responsible for an approximately seven-fold destabilization of the complete synaptic junction (9-s synapsis in the absence of PAXX). We likewise determined that disabling the XRCC4-XLF-ligase IV system is responsible for an ~30-fold destabilization of the complete synaptic junction (2-s synapsis when DNA-PK and PAXX were not supplemented with XRCC4-XLF-ligase IV). Because the lifetime of a complex is related to its free energy of activation by Boltzmann's law, we estimate that PAXX contributes k B T ln(66 s/9 s) ≈ 2 k B T or 1.2 kcal/mol to the stability of the complete synaptic junction, whereas XRCC4-XLF-ligase IV contributes k B T ln(66 s/2 s) ≈ 3.5 k B T or 2.1 kcal/mol to the stability of the complete synaptic junction. Together, these two sets of components would stabilize the synaptic state by roughly 5.5 k B T, increasing its lifetime nearly 200fold. These results suggest that the primary synapsis formed by the DNA-PK holoenzyme alone is short lived, in the range of hundreds of milliseconds. Lastly, in an attempt to observe this short-lived interaction, we increased the rate at which the force is switched between low and high values by a factor of ten. The large number of traction cycles generated allowed us to detect rare and short-lived synaptic events of expected synaptic amplitude ( Supplementary  Fig. 6 ). The lifetime of this synapsis is, as predicted, in the 100 ms range. Control experiments showed that this short-lived and specific synapsis is only observed in the presence of DNA-PKcs and Ku (Supplementary Fig. 6 and Supplementary Table 2 ).
The additive nature of these short-lived and weak interactions, revealed by the present single-molecule experiments, suggests a multivalent system in which multiple protein interfaces stabilize DNA end synapsis. Use of multiple, weak interactions to obtain high affinity balanced by regulation is an emerging common theme in DNA repair systems; one example is RPA, whose subnanomolar affinity is built on multiple weak interactions 33 . Longer synapsis effectively increases the probability of ligation.
Our work supports and broadens the observation that PAXX stabilizes the core NHEJ proteins at damaged chromatin 11,31,32 and suggests PAXX as a potential target for cancer drug development. Indeed, removing PAXX from the complete reaction reduces the probability of repair from 72% to 28% but does not completely abolish repair-as is the case when XLF or XRCC4 are omitted from the NHEJ reaction (Table 1) . It remains to be determined whether PAXX can incorporate into NHEJ complexes only at the Complete reaction  50  26  7  2  1  -----36  72 ± 12  100 Complete but for DNA-PKcs 40
Complete but for Ku 69
Complete but for PAXX 57
Complete but for XLF 184
Complete but for XRCC4 NTD/CTD
Complete but for ligase IV 102
Ligation events were identified as an irreversible shortening of the DNA scaffold's extension by Δ l ~165 nm. For the complete reaction, 28 of the 36 molecules scored for repair were further confirmed by DNA cleavage via SmaI digest (Fig. 1c) ; the remaining eight molecules were lost from tracking during SDS washes, which can destabilize streptavidin and antidigoxigenin links between DNA and surfaces).
initial stage of assembly or whether it may also join at later stages of assembly, for instance, once XRCC4-XLF-ligase IV has assembled. With this validated single-molecule system, it will now be feasible to examine the impacts of other components that act in NHEJ, such as Artemis and APLF 34 proteins, as well as noncoding RNA 35 , and relate their energetic and mechanistic roles to cancer predispositions arising from mutational defects or aberrant regulation. Our present results show that novel and functional DNA scaffolds provide unique and unexpected kinetic insights into the protein machinery that is responsible for carrying out NHEJ in human cells. Our studies thus provide a solid foundation upon which to further explore both the order of assembly and the stoichiometry of functional repair complexes using fluorescently labeled protein variants and correlative single-molecule nanomanipulation and fluorescence (NanoCOSM 36 ). Importantly, the measurements of synapsis lifetime and k B T-scale energetics uncover the nature of multicomponent DNA-break repair complexes. This knowledge has broad scientific and biomedical implications, including strategies for targeting the DNA damage response by small molecules. Specifically, we propose a strategy of chemical inhibitors to compete with the functionally important yet individually weak interactions in this major system for DNA double-strand break repair in humans.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0065-1. interplay between end-processing and end-ligation during nonhomologous end-joining. 
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Methods DNA construct. The construct is assembled from two precursor dsDNA molecules. For the first molecule, we assemble two ssDNA oligos, one short and one long, into a covalently linked, asymmetric branched structure. In a PCR reaction using a pair of such branched oligos, the longer oligos prime PCR while the shorter ones remains unused. The branch points end up 67 bp from the end of dsDNA. This 'break' PCR product is 3 kb in length, and by hybridization, one can convert the remaining ssDNA branches into dsDNA branches with 4-bp overhangs. This fragment can then be circularized by hybridization and ligation to a ~600 bp bridge DNA fragment, which is simply a standard dsDNA fragment digested so as to have overhangs compatible with those of the short dsDNA branches. The circularized DNA can then be reopened with a pair of restriction enzymes and gel purified to obtain the desired product, namely, two 1.5 kbp DNA segments connected to each other via an internal DNA bridge anchored 67 bp from the closest DNA ends. Finally, one of the 1.5 kbp fragments is ligated to a biotin-labeled dsDNA fragment (at the extremity distal to the anchor), while the other 1.5 kbp fragment is ligated to a digoxigenin-labeled dsDNA fragment (at the extremity distal to the anchor). The construct, assembled to a micron-size magnetic bead at the biotin-labeled end and a treated glass coverslip at the dig-labeled end can then be handled and observed in a magnetic trap (~30-50 constructs per field of view). The ends can be processed into blunt or overhang ends by restriction digest either after ligation to the biotinand dig-labeled fragments or directly under the magnetic trap.
Oligonucleotides DBCO-Hyb1 5′ YCCATGGGCATACTGATCGGTAGGG and DBCO-Hyb2 5′ YGAGCCAAGACGCCTCCATCCATGCA, where Y indicates DBCO-dT (courtesy of J. Randolph, Glen Research, USA), and oligos Az-Charomid-1456-SmaI (5′ G AG AG A CC CG GG C AC CG TC TC CT-TCGAACTTATTCG C AA TG GA GT GT CA TT CA TC AA GG AC GC CG C Z AT-CGCAAATGGTGCTATCC) and Az-Charomid-3778-SmaI (5′ G AG AGACCCG GGCACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCA GAGCGAGGZATGTAGGCGGTGCTACAGAG), where Z represents Azido-dT (Trilink, USA) and the underlined sequence is the SmaI/XmaI restriction site, were resuspended to 10 μ g/μ l in formamide at 37 °C. 50 μ g each of oligos DBCO-Hyb1 and Az-Charomid-1456 were combined. Similarly, 50 μ g each of DBCO-Hyb2 and Az-Charomid-3778 were combined. Combined oligos were incubated 8 h at 37 °C, and products corresponding to covalently coupled oligos were separated on an 8 M urea, 8% acrylamide/bisacrylamide (29:1) gel running at ~10 V/cm in 1 × Trisborate-EDTA buffer. Gel slices corresponding to product were excised from the gel, using a sacrificial imaging lane to carry out UV shadowing to identify the relevant bands. DNA was purified by first eluting DNA from the crushed gel fragment overnight in 10 mM phosphate buffer pH 8.0 with agitation at 4 °C. A SepPak C18 cartridge (Waters) was conditioned with first acetonitrile and then water; the eluate was loaded onto the cartridge, which was then washed with water, and the oligo released from the cartridge by eluting with acetonitrile. Acetonitrile was evaporated under vacuum centrifugation, and oligo was resuspended to ~10 μ M. The coupled oligos were then used as primers in a PCR reaction using Charomid 9-5 Δ SbfI as template (i.e., a Charomid 9-5 plasmid derivative from which the native SbfI site has been removed by SbfI digestion, fill-in and religation), and ~3 kbp product DNA was purified using agarose gel electrophoresis and extraction (Macherey-Nagel).
Next, the covalently coupled oligos that do not participate in the PCR reaction were annealed, respectively, to ssDNA oligos O1-Comp (5′ Pho-CGCGCCCTACCGATCAGTATGCCCATGGA, complementary to DBCO-Hyb1 but allowing formation of an AscI overhang compatible with ligation to an MluI overhang as well as an AscI overhang) and O2-Comp (5′ Pho-TGGATGGAGGCGTCTTGGCTCA, complementary to DBCO-Hyb2 but allowing formation of an NsiI overhang, compatible with ligation to an SbfI overhang as well as an NsiI overhang) in equimolar ratio at a final concentration of ~300 nM each for 1 h at room temperature in 1 × CutSmart buffer (New England Biolabs).
Precursor to the bridge DNA was obtained by PCR amplification of Charomid C9-5 Δ SbfI template with oligos Charo-3600-MluI (5′ GAGAGAACGCGTTACCTGTCCGCCTTTCTCCCTTCGGG) and Charo-4230-SbfI (5′ GAGAGACCTGCAGGC CTCACTGATTAAGCATTGGTAACTGTCAGACC), digesting with MluI and SbfI, and agarose gel separation and extraction (Macherey-Nagel).
Break DNA and precursor to bridge DNA, prepared as above, were combined at ~130 nM final concentration each in 1 × CutSmart buffer (New England Biolabs), along with 0.5 μ l each of SbfI, MluI-HF, NsiI and AscI, HC-T4 DNA ligase (New England Biolabs), and 1 mM ATP and 1 mM DTT, and left overnight at room temperature. After 20 min heat inactivation at 65 °C, the DNA was digested with XbaI and SacI. This resulted in a linear ~3.6 kbp DNA product consisting of the ~690 bp bridge segment in the center and two linear 1.5 kbp DNA segments at each end anchored to the bridge set internally ~58 bp from a SmaI/XmaI restriction site. This 3.6 kbp fragment was purified by agarose gel separation and extraction (Macherey-Nagel). The DNA was finally ligated to biotin-labeled ~1 kbp DNA bearing an XbaI site and digoxigenin-labeled ~1 kbp DNA bearing a SacI site for attachment in the magnetic trap to, respectively, streptavidin-coated magnetic bead and antidigoxigenin-modified glass surface. In this 10 μ l ligation reaction conducted in the manufacturer's recommended conditions (New England Biolabs T4 DNA ligase buffer 1 × ), the DNA was at a concentration of 3 nM, the biotin-and dig-labeled fragments were each at 10 nM concentration, and 200 units (0.5 μ l) of T4 DNA ligase were used to ligate the DNA for 3 h at room temperature before thermally inactivating the ligase.
To complete preparation of the DNA ends, we then carried out overnight digestion of 1 μ l of this DNA preparation in a final reaction volume of 10 μ l using either 10 units of XmaI (New England Biolabs) or 20 units of SmaI (New England Biolabs) restriction enzyme. Restriction enzyme was heat inactivated as per manufacturer recommendation, and the construct was diluted threefold to a nominal DNA concentration of 100 pM and stored at -20 °C. For experiments conducted using dephosphorylated DNA as a substrate for NHEJ, we dephosphorylated the construct by combining into a 10 μ l reaction volume 2 units of Antarctic Phosphatase (New England Biolabs) and 0.6 fmoles of the ligation product obtained in the previous paragraph. The reaction was allowed to proceed for 1 h at 37 °C before being thermally inactivated as per manufacturer's recommendation.
For assembly onto the microscope, the ligation reaction was first diluted 60-fold to 50 pM nominal concentration of DNA in Tris buffer (10 mM Tris-HCl, pH 8). Then, 0.5 μ l of this dilution was mixed with 10 μ l of Dynal MyOne C1 magnetic beads. The beads were prepared by taking 10 μ l of stock solution, washing them with 100 μ l of RB (20 mM K·HEPES, pH 7.8, 100 mM KCl, 5 mM MgCl 2 , 1 mM ATP, 1 mM DTT, 0.05% Tween-20, and 0.5 mg/ml BSA) and concentrating the beads, discarding the supernatant, and resuspending the beads in 10 μ l of RB. The bead + DNA mixture was diluted after 5-10 s with an additional 15 μ l of RB and injected onto functionalized surfaces.
Functionalized surfaces consist in two glass coverslips (#1, ~180 μ m thick) separated by two thicknesses of parafilm into which a channel (1 mm × 50 mm) has been cut. Both coverslips were functionalized with antidigoxigenin and passivated as described recently 39 , but one of the coverslips had 2-mm-diameter holes located above each end of the channel, which are used for filling and draining the reagentfilled channel. The surface was mounted on a custom-designed holder and placed atop the oil-immersion objective of a magnetic trap, in which a pair of high-grade permanent magnets located above the sample can be translated (to vary the force) or rotated (to rotate the bead and supercoil the DNA) to modify the mechanical constraints applied to the DNA. Real-time particle tracking software (PicoJai SARL) allows video microscopy-based tracking of the 1-µ m magnetic beads with nanometer resolution and in real time (~30 Hz).
A typical sample consisted of, in a microscope field of view, ~30-50 individual DNA tethers, which can be monitored simultaneously. These tethers were systematically verified to display an appropriate change in DNA extension when the applied force was varied from F low = 0.04 pN to F high = 1.4 pN, and, when necessary, were further verified to not change extension when supercoiling changed.
Protein expression constructs. Ku70 and Ku80 were both cloned into pFastBac Dual vector (Thermo Fisher) and coexpressed in insect Sf9 cells. Ku70 contains an N-terminal hexahistidine tag followed by a TEV cleavage site. XLF and XRCC4 were individually cloned into a pHAT5 vector 40 and transformed into Rosetta2 (DE3) cells (Invitrogen). Both XLF and XRCC4 contain a C-terminal hexahistidine tag. Cell cultures were grown in LB medium until OD 600 was approximately 0.6. IPTG was added to a final concentration of 1 mM. Proteins were expressed at 16 °C overnight for XLF and at 37 °C for 4 h for XRCC4. The PAXX and full-length ligase IV-XRCC4 coexpression constructs were as described previously 11, 41 . XLF 1-233 (C-terminal truncation mutant, which cannot bind to Ku70/80) was cloned into pETG-41A (Gateway Destination vector, EMBL) and expressed as descripted previously 42 . The catalytically dead ligase IV(K273A)-XRCC4 protein complex was generated from the ligase IV-XRCC4 coexpression plasmid (a gift from M.-D. Tsai, The Ohio State University, Columbus, OH) by the QuikChange method (Agilent Technologies). Full-length ligase IV fused with a hexahistidine tag at the C terminus and ccXRCC4 (residues 138-213) were amplified from the ligase IV-XRCC4 coexpression plasmid and an XRCC4 plasmid, of which cysteines were mutated to alanines, respectively, and cloned into pRSFDuet1 vector (Novagen).
Protein purifications. Ku70/80. Insect Sf9 cells containing Ku70/80 were lysed by sonication in lysis buffer (50 mM Tris-HCl, pH 8.0, 5% glycerol, 150 mM NaCl, 2 mM β -mercaptoethanol, 20 mM imidazole, protease inhibitor (Roche) and 40 μ g/ml DNase I (Sigma)). After 30 min incubation in 4 °C after sonication, the salt concentration of the lysate was adjusted to 500 mM NaCl. After centrifugation, Ku70/80 supernatant was mixed with Ni-NTA affinity resin (Qiagen) pre-equilibrated with binding buffer (50 mM Tris-HCl, pH 8.0, 5% glycerol, 500 mM NaCl, 2 mM β -mercaptoethanol, and 20 mM imidazole). After beads were washed with binding buffer for 10 × column volumes, protein was eluted using elution buffer (50 mM Tris-HCl, pH 8.0, 5% glycerol, 500 mM NaCl, 2 mM β -mercaptoethanol, and 100 mM imidazole). The N-terminal hexahistidine tag of Ku70 was cleaved by TEV protease. Uncleaved Ku70/80 and TEV (also hexahistidine-tagged) were removed by running through a gravity column containing Ni-NTA resin. The flow through containing Ku70/80 was dialyzed with Q column (GE Healthcare) buffer A (20 mM Tris-HCl, pH 8, 50 mM NaCl, 5% glycerol, and 5 mM DTT) and loaded onto the column. Protein was eluted in a gradient against buffer B (20 mM Tris-HCl, pH 8, 1 M NaCl, 5% glycerol, and 5 mM DTT). Eluted sample was further purified by running through Superdex 200 10/300 (GE Healthcare) equilibrated in Buffer GF (20 mM Tris-HCl, pH 8, 150 mM NaCl, 5% glycerol, and 5 mM DTT). Protein samples were analyzed on 4-12% NuPAGE Bis-Tris gels, concentrated and stored in -80 °C.
XLF and XRCC4. XLF cells were purified by a similar process as for Ku70/80. The lysis buffer for XLF is 20 mM HEPES, pH 8.0, 2 M NaCl, 10 mM imidazole, 2 mM β -mercaptoethanol and protease inhibitor). No cleavage was carried out for the elution sample from after Ni affinity purification. The Q column for XLF is buffer A (20 mM HEPES, pH 8.0, 10 mM NaCl, and 5 mM DTT) and buffer B (20 mM HEPES, pH 8.0, 1 M NaCl, and 5 mM DTT). The final gel filtration buffer is 20 mM HEPES, pH 8.0, 150 mM NaCl, and 5 mM DTT. Purification of XRCC4 was performed as described previously 43 . Purification of XLF was identical to that of wild-type XLF, except that the mutant contained an N-terminal hexahistidine-MPB tag followed by a TEV cleavage site. After Ni affinity purification, the tag was cleaved before proceeding to the Q column.
Ligase IV-XRCC4, PAXX and DNA-PKcs. Purifications of all ligase IV-XRCC4 constructs, PAXX and DNA-PKcs were performed as described previously 5, 11, 41 .
Bulk ligation of DNA with overhang ends by XRCC4-ligase IV system. pHAT4 was double-digested with XhoI and NcoI to generate 4-bp overhangs. 200 ng of the digested plasmid was incubated with 25 nM of the indicated proteins in 20 ml of reaction buffer containing 25 mM Tris-HCl, pH 7.5, 150 mM KCl, 1 mM MgCl 2 , 1 mM DTT, 10 μ M ATP, 10% (wt/vol) PEG10,000, and 10 μ g/ml BSA. Mixtures were incubated at 37 °C for 5 min before initiating ligation by XRCC4-ligase IV at 37 °C for 30 min. The mixtures were incubated at 50 °C for another 30 min after adding 2 μ l of a reaction-stop solution (100 mM EDTA, 0.1% (wt/vol) SDS) and 0.2 μ l of 20 mg/ml Proteinase K. Reaction mixtures were separated by electrophoresis on a 0.8% agarose gel in TBE buffer. The gel was stained with SYBR Gold, visualized using a UV imager and quantified using GeneTools (Synegene). We note that the presence of 4-bp overhangs makes this assay more permissive than the blunt ends used in the scaffold assay.
Experimental conditions. All assays were conducted at 34 °C in reaction buffer RB (20 mM K·HEPES, pH 7.8, 100 mM KCl, 5 mM MgCl 2 , 1 mM ATP, 1 mM DTT, 0.05% Tween-20, and 0.5 mg/ml BSA), unless noted otherwise. When present, NHEJ components were used at a concentration of 10 nM Ku70/80 (dimer), 100 pM DNA-PKcs, 20 nM PAXX, 20 nM XRCC4, 20 nM XLF, and 20 nM ligase IV. When mutated versions of proteins were used, they were at the same concentration as wild-type proteins.
To digest DNA molecules that have undergone NHEJ and repair under the magnetic trap, we first disrupted any remaining components of the repair machinery by rinsing the capillary with wash buffer supplemented with 0.2% SDS (wash buffer: 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 0.05% Tween-20, and 0.5 mg/ml BSA), then rinsing the capillary with wash buffer, and then infusing the capillary with 100 μ l of RB containing either 20 units of XmaI or 10 units of SmaI (New England Biolabs). Data presented in histograms of changes in DNA extension upon NHEJ repair or T4-based ligation were obtained by comparing DNA extension before and after cleavage.
Data collection and analysis. Single-molecule magnetic trapping data giving DNA extension as a function of time and under force-modulation cycles were obtained using the Picotwist software suite (Picotwist S.A.R.L). Magnetic trapping was carried out as has been described previously 26, 39 . In the magnetic trap used, the magnetic bead z position was tracked at 31 Hz to ~5 nm resolution for F = 1.4 pN.
Unless noted otherwise, force was repeatedly alternated between low (F low = 0.04 pN) and high (F high = 1.4 pN) with a total cycle time of typically 450 s (~225 s at F low followed by ~225 s at high force). For experiments presented in Supplementary Figs. 2  and 6 , the total cycle time was about 50 s (25 s at low force followed by 25 s at high force).
Time traces of DNA extension versus time were analyzed to determine the lifetime (t synapsis ) and extension change (Δ l) upon rupture of individual interaction events observed on the scaffold after the extending force had been increased from low to high force.
Finally, to determine the frequency of synaptic events, we included all events with expected amplitude-change signature for specific end-end interactions (i.e., within three s.d. of the mean or Δ l between 130 and 200 nm). In this calculation, we also accounted for apparently irreversible events characteristic of ligation, as well as long-lived events that end up reversing apparently after multiple traction cycles.
Events for which rupture did not take place within the same traction cycle in which the event was first observed but instead ruptured in later traction cycles could not be reliably assessed for continuity or scored for t synapsis and were therefore excluded from (t synapsis , Δ l) analysis. Such long-lived events lasting thousands of seconds were observed in the presence of downstream components (XLF, XRCC4, and ligase IV), particularly in the 'complete' reaction, for which they represent approximately half of all events. When any one of the downstream components was removed, these long-lived events spanning at least two traction cycles were no more than 10% of all observed events. No such long-lived events were observed when only upstream components (Ku, DNA-PKcs, and PAXX) were present. We note that the extended lifetime of such events precludes their detection by fluorescence-based methods, which are essentially unable to access such timescales. We further note that the amplitude of such long-lived events was systematically within the expected range for bona fide synaptic events, but the very long-lived nature of these events suggests an alternative conformation or state of one of the NHEJ components employed.
Statistics and reproducibility. Data were collected from at least 50-100 monitored DNA molecules observed over the course of at least two independent experimental replicates, and events were distributed according to a Poisson law among DNA molecules, with ~1-3 events per DNA molecule generating interactions (with typically at least ~30% of the 50-100 DNA molecules monitored reporting interactions).
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. Data availability. The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
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